ith limited capacity to store adenosine triphosphate (ATP) in the form of glycogen and phosphocreatine, the heart is continuously dependent on ATP synthesis to maintain force generation, myofibrillar relaxation, and ionic homeostasis. The ability of normal myocardium to adapt its substrate use to meet these essential demands has been appreciated for over half a century. Central in this adaptation is the flexible metabolic circuitry that is capable of switching preferred energy substrates and regulating pathways of oxidative and nonoxidative energy transduction to optimally adapt to physiological demands (1). Normally, fatty acids (FAs) are the predominant energetic substrate for the heart; their beta-oxidation provides 60% to 70% of myocardial ATP, with 30% of ATP derived from glucose.
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In heart failure with reduced ejection fraction, both animal models and human studies demonstrate alterations in the otherwise versatile capacity of the myocardium to use alternative substrates. Sack et al. 
